Register entry
REMPEX PHARMACEUTICALS INC A WHOLLY OWNED SUB OF MELINTA THERAPEUTICS LLC
- Registered sites
- 0
- Active NDC listings
- 0
- Live patents
- 14
- Exclusivities
- 1
- Countries
- 0
Exclusivity
Patents and exclusivities
14| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 12161656 | MINOCINminocycline hydrochloride | product | May 2031 |
| 9084802 | MINOCINminocycline hydrochloride | use | May 2031 |
| 9278105 | MINOCINminocycline hydrochloride | use | May 2031 |
| 10172874 | VABOMEREmeropenem; vaborbactam | product | Aug 2031 |
| 10183034 | VABOMEREmeropenem; vaborbactam | use | Aug 2031 |
| 10561675 | VABOMEREmeropenem; vaborbactam | use | Aug 2031 |
| 11007206 | VABOMEREmeropenem; vaborbactam | use | Aug 2031 |
| 12171772 | VABOMEREmeropenem; vaborbactam | substance | Aug 2031 |
| 9694025 | VABOMEREmeropenem; vaborbactam | use | Aug 2031 |
| 8680136 | VABOMEREmeropenem; vaborbactam | substance, product | Aug 2031 |
| 11944634 | MINOCINminocycline hydrochloride | product | Oct 2032 |
| 12478606 | VABOMEREmeropenem; vaborbactam | use | Jan 2038 |
| 11376237 | VABOMEREmeropenem; vaborbactam | use | Apr 2039 |
| 12533342 | VABOMEREmeropenem; vaborbactam | use | Apr 2039 |
| Product | Exclusivity | Until |
|---|---|---|
| VABOMEREMEROPENEM; VABORBACTAM | GAIN Qualified infectious disease product (GAIN) | Aug 2027 |
Enquiry
Common questions
- Is REMPEX PHARMACEUTICALS INC A WHOLLY OWNED SUB OF MELINTA THERAPEUTICS LLC FDA approved?
- REMPEX PHARMACEUTICALS INC A WHOLLY OWNED SUB OF MELINTA THERAPEUTICS LLC holds no registered establishment of its own; it appears here on its Orange Book patents.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.